Enters Settlement Agreement With MD Anderson - SEC Filing
Adaptimmune Therapeutics PLC ADAP.O: ADAPTIMMUNE THERAPEUTICS PLC - ENTERS SETTLEMENT AGREEMENT WITH MD ANDERSON - SEC FILING ADAPTIMMUNE THERAPEUTICS PLC - SETTLEMENT AGREEMENT INCLUDES RELEASE AND DISMISSAL OF CLAIMS - SEC FILING ADAPTIMMUNE THERAPEUTICS PLC - PAYMENT OBLIGATIONS UNDER SETTLEMENT NOT MATERIAL TO ADAPTIMMUNE - SEC FILING Source text: [ID:n0001558370-25-009278] Further company coverage: ADAP.O
Recent news on Adaptimmune Therapeutics
See all newsAdaptimmune Therapeutics PLC reports results for the quarter ended June 30 - Earnings Summary
Adaptimmune Therapeutics PLC expected to post a loss of 10 cents a share - Earnings Preview
Enters Settlement Agreement With MD Anderson - SEC Filing
Adaptimmune Therapeutics PLC reports results for the quarter ended March 31 - Earnings Summary
Adaptimmune Therapeutics PLC expected to post a loss of 12 cents a share - Earnings Preview